Dispensing Evaluation of a Galyfilcon A Prototype Lens and a Marketed Contact Lens

Launched by JOHNSON & JOHNSON VISION CARE, INC. · Aug 12, 2010

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The subject is a current spherical soft contact lens wearer and willing to wear the study lenses on a daily wear basis for the duration of the study.
• • The subject's optimal vertexed spherical equivalent distance correction must be between -1.00 and - 5.00D.
• • Any cylinder power must be ≤ -0.75D.
• • The subject must have visual acuity best correctable to 20/25+3 or better for each eye.
• • The subject must read and sign the Statement of Informed Consent.
• • The subject must appear able and willing to adhere to the instructions set forth in the clinical protocol.
• Exclusion Criteria:
• • Ocular or systemic allergies or disease which might interfere with contact lens wear.
• • Systemic disease or use of medication which might interfere with contact lens wear.
• • Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining, or any other abnormalities of the cornea which would contraindicate contact lens wear.
• • Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection which might interfere with contact lens wear.
• • Any ocular infection.
• • Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
• • Pregnancy or lactation.
• • Diabetes.
• • Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease (e.g. HIV).
• • Habitual contact lens type is toric, multifocal, or is worn as extended wear.